ARGNF:OTCMKTS
argenx SE
936,00 US$
0,00%
(0,00) 1D
1. okt., 14.37.17 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for ARGNF...
Markedsværdi
50,06 mia.
Gns. vol.
14,00
Volumen
0,00
Højeste i 52 uger
1.020,00 US$
Laveste i 52 uger
708,72 US$
Beta
0,46
Aktier i omløb
62,89 mio.
Antal ansatte
2 t
Markedsværdi
50,06 mia.
Gns. vol.
14,00
Volumen
0,00
Højeste i 52 uger
1.020,00 US$
Laveste i 52 uger
708,72 US$
Beta
0,46
Aktier i omløb
62,89 mio.
Antal ansatte
2 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Simply Wall Street
·
for 9 timer siden
Could A Halted Sjögren Trial Alter The Investment Case For argenx Stock?
Yahoo Finance
·
for 14 timer siden
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
AD HOC NEWS
·
for 1 dag siden
Argenx stock at EUR 724.80, market value USD 50.7 billion
Investing.com
·
for 1 dag siden
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Om argenx SE